BlackRock Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.68M Sell
55,273
-76,846
-58% -$5M ﹤0.01% 1253
2016
Q3
$8.75M Buy
132,119
+7,443
+6% +$509K 0.01% 917
2016
Q2
$9.03M Buy
124,676
+118
+0.1% +$8.11K 0.01% 871
2016
Q1
$8.05M Buy
124,558
+1,754
+1% +$116K 0.01% 899
2015
Q4
$8.8M Buy
122,804
+101,568
+478% +$7.51M 0.01% 896
2015
Q3
$1.63M Buy
21,236
+6,824
+47% +$551K ﹤0.01% 1424
2015
Q2
$1.07M Buy
14,412
+379
+3% +$27.3K ﹤0.01% 1623
2015
Q1
$1.02M Sell
14,033
-826
-6% -$57.4K ﹤0.01% 1551
2014
Q4
$982K Hold
14,859
﹤0.01% 1511
2014
Q3
$815K Sell
14,859
-240
-2% -$13.6K ﹤0.01% 1569
2014
Q2
$878K Hold
15,099
﹤0.01% 1591
2014
Q1
$936K Buy
15,099
+515
+4% +$30K ﹤0.01% 1590
2013
Q4
$778K Buy
14,584
+732
+5% +$39.3K ﹤0.01% 1688
2013
Q3
$695K Buy
13,852
+66
+0.5% +$3.22K ﹤0.01% 1672
2013
Q2
$631K Buy
+13,786
New +$617K ﹤0.01% 1659

Other funds holding MD

BlackRock Advisors's MD Position: Q4 2016 in Review

BlackRock Advisors reduced its Pediatrix Medical (MD) stake by 58% in Q4 2016, selling an estimated $5M and leaving 55,273 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

BlackRock Advisors first reported a position in MD in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.03M in Q2 2016. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

  • BlackRock Advisors held 55,273 shares of Pediatrix Medical worth $3.68M as of Q4 2016.
  • BlackRock Advisors sold 76,846 Pediatrix Medical shares in Q4 2016, an estimated $5M.
  • Pediatrix Medical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1253 holding.
  • BlackRock Advisors first reported a position in Pediatrix Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Pediatrix Medical position peaked at $9.03M in Q2 2016.
  • 383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.